EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) announced today that it will be presenting a scientific poster and abstract at the Eighth Annual Diabetes Technology Meeting in Bethesda, Maryland, November 13-15, 2008. The data relate to the use of NasulinTM, the Company’s proprietary intranasal insulin spray, in treatment of type 2 diabetic patients.
